Cargando…
JL1, a novel differentiation antigen of human cortical thymocyte
Expression of a novel thymocyte differentiation antigen, JL1, defined by a monoclonal antibody (mAb) developed against human thymocytes showed a specificity for stage II double positive (CD4+CD8+) human cortical thymocytes. This antigen was not expressed at detectable levels on medullary thymocytes,...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2191218/ https://www.ncbi.nlm.nih.gov/pubmed/8376947 |
Ejemplares similares
-
Immunotherapeutic potential of JL1, a thymocyte surface protein, for leukemia.
por: Kim, T. J., et al.
Publicado: (1998) -
Peptides Regulate Cortical Thymocytes Differentiation, Proliferation, and Apoptosis
por: Khavinson, V. Kh., et al.
Publicado: (2011) -
JL1 Antigen Expression on Bone Marrow Lymphoma Cells from Patients With Non-Hodgkin Lymphoma
por: Kim, Min-Sun, et al.
Publicado: (2020) -
Polymake.jl: A New Interface to polymake
por: Kaluba, Marek, et al.
Publicado: (2020) -
The Incidence and Immunophenotypic and Genetic Features of JL1 Expressing Cells and the Therapeutic Potential of an Anti-JL1 Antibody in De Novo Pediatric Acute Leukemias
por: Park, Sang Hyuk, et al.
Publicado: (2019)